Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition Yields Promising Future Implications

被引：0

作者：

Kaiser, Carl ^{[1
]}

Klestinski, Keith ^{[1
]}

Tsuji, J. ^{[1
]}

Sabatino, T. ^{[1
]}

Yorke, N. ^{[1
]}

Johnson, R. ^{[1
]}

Arnhold, K. ^{[1
]}

Otten, J. ^{[1
]}

Ahn, P. ^{[1
]}

Cephus, K. ^{[1
]}

Dittlof, A. ^{[1
]}

Ortega, L. ^{[1
]}

Foster, H. ^{[1
]}

Hernandez, M. ^{[1
]}

Rivera, M. ^{[1
]}

Strom, D. ^{[1
]}

Strom, J. ^{[1
]}

Yang, N. ^{[1
]}

Dittrich, N. ^{[1
]}

Waas, Matthew ^{[2
]}

机构：

[1] Marquette Univ, High Sch, Sci, Milwaukee, WI 53233 USA

[2] Med Coll Wisconsin, Biochem, Milwaukee, WI 53226 USA

来源：

FASEB JOURNAL | 2015年 / 29卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

LB61

引用

页数：1

共 50 条

[1] Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Sampath, Deepak
Zabka, Tanja S.
Misner, Dinah L.
O'Brien, Thomas
Dragovich, Peter S.
PHARMACOLOGY & THERAPEUTICS, 2015, 151 : 16 - 31
[2] Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review
Gasparrini, Massimiliano
Giovannuzzi, Simone
Nocentini, Alessio
Raffaelli, Nadia
Supuran, Claudiu T.
EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (07) : 565 - 582
[3] INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) ATTENUATES EXPERIMENTAL PULMONARY HYPERTENSION
Chen, J.
Sysol, J. R.
Shioura, K. M.
Singla, S.
Yamamura, H.
Yamamura, A.
Reddy, V.
Torres, J.
Sridhar, A.
Tang, H.
Yuan, J. X.
Garcia, J. G.
Machado, R. F.
JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (04)
[4] IS NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) THE MARKER FOR OSTEOBLAST DIFFERENTIATION?
He, X.
He, J.
Lin, L.
Zhang, L.
Li, Y.
OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S578 - S578
[5] Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
Galli, Ubaldina
Travelli, Cristina
Massarotti, Alberto
Fakhfouri, Gohar
Rahimian, Reza
Tron, Gian Cesare
Genazzani, Armando A.
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (16) : 6279 - 6296
[6] Metabolomics Analysis of Metabolic Effects of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on Human Cancer Cells
Tolstikov, Vladimir
Nikolayev, Alexander
Dong, Sucai
Zhao, Genshi
Kuo, Ming-Shang
PLOS ONE, 2014, 9 (12):
[7] Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) prevents cytokine-mediated beta cell dysfunction
Egbase, D.
Butterworth, S.
Greally, J.
Sayers, S.
Evans, E.
Bewick, G.
Tsakmaki, A.
Smith, L.
Persaud, S.
Caton, P.
DIABETIC MEDICINE, 2020, 37 : 37 - 37
[8] Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death
Velma, Ganga Reddy
Krider, Isabella S.
Alves, Erick T. M.
Courey, Jenna M.
Laham, Megan S.
Thatcher, Gregory R. J.
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 5999 - 6026
[9] Nicotinamide phosphoribosyltransferase (NAMPT): a new cytokine in tumor progression
Grolla, Ambra
Torretta, Simone
Amoruso, Anpla
Orsomando, Giuseppe
Genazzani, Armando
CANCER RESEARCH, 2015, 75
[10] Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities
Chen, Hang
Wang, Shiyu
Zhang, Haiyuan
Nice, Edouard C.
Huang, Canhua
EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (08) : 827 - 838

← 1 2 3 4 5 →